Results 41 to 50 of about 1,551 (70)

Combination therapy with interferon and ruxolitinib for polycythemia vera and myelofibrosis: are two drugs better than one?

Haematologica, 2020
Richard T. Silver
doaj   +1 more source

Молекулярно-генетична система діагностики хронічних мієлопроліферативних новоутворень

Фактори експериментальної еволюції організмів, 2014
Aims. The myeloproliferative neoplasms (MPNs) are a group of diseases characterized by the rapid growth of abnormal uncontrolled proliferation myeloid cells.
M. В. Дибков, М. П. Завелевич, Д. Ф. Глузман, Л. О. Поліщук, О. В. Малюта, С. С. Малюта, Г. Д. Телегеєв   +6 more
doaj  

Evaluation of bone marrow morphology is essential for assessing disease status in recombinant interferon α-treated polycythemia vera patients

Haematologica, 2017
Elizabeth Margolskee, Spencer Krichevsky, Attilio Orazi, Richard T. Silver   +3 more
doaj   +1 more source

Evaluation of the association between the JAK2 46/1 haplotype and chronic myeloproliferative neoplasms in a Brazilian population

Clinics, 2013
OBJECTIVE: The JAK2 46/1 haplotype has recently been described as a major contributing factor to the development of myeloproliferative neoplasm, whether positive or negative forthe JAK2 V617F mutation.
Sarah Pagliarini-e-Silva, Bruna Cunha Santos, Elizangela Mendes de Figueiredo Pereira, Mari Ellen Ferreira, Elaine Cristina Baraldi, Ana Maria Sell, Jeane Eliete Laguila Visentainer   +6 more
doaj  

An agenda for future research projects in polycythemia vera and essential thrombocythemia

Haematologica, 2020
Tiziano Barbui, Alessandro Maria Vannucchi, Paola Guglielmelli, Valerio De Stefano, Alessandro Rambaldi   +4 more
doaj   +1 more source

Are thrombosis, progression, and survival in ET predictable?

Blood Cancer Journal
Ghaith Abu-Zeinah, Katie Erdos, Neville Lee, Ahamed Lebbe, Imane Bouhali, Mohammed Khalid, Richard T. Silver, Joseph M. Scandura   +7 more
doaj   +1 more source

Myeloproliferative neoplasms

HemaSphere, 2018
Jean-Jacques Kiladjian
doaj   +1 more source

Myeloproliferative neoplasms

HemaSphere, 2019
Nick Cross, (Coordinating Author)
doaj   +1 more source

Genomic characterization of spleens in patients with myelofibrosis

Haematologica, 2018
Eran Zimran, Joseph Tripodi, Raajit Rampal, Franck Rappoport, Sharon Zirkiev, Ronald Hoffman, Vesna Najfeld   +6 more
doaj   +1 more source

Somatic mutations of calreticulin in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms

Haematologica, 2014
Luca Malcovati, Elisa Rumi, Mario Cazzola   +2 more
doaj   +1 more source